Durvalumab after concurrent chemoradiotherapy in a patient with chemotherapy-resistant unresectable stage III non-small ...
Case Report
Durvalumab after concurrent chemoradiotherapy in a patient with chemotherapy-resistant unresectable stage III non-small cell lung cancer: a case report
Tao Zhang, Yuqi Wu, Shan Zheng, Guowei Cheng, Xiangling He, Nan Bi